Rectal cancer is a type of colorectal cancer that develops in the rectum, the final section of the large intestine. Treatment depends on the location and size of the tumour, whether lymph nodes or other organs are involved, the cancer stage, the tumor’s molecular characteristics, and the patient's overall health.
Modern Rectal Cancer treatment may involve a combination of Surgery, Chemotherapy, Radiation Therapy, Chemoradiation, Targeted Therapy And Immunotherapy. For selected patients, treatment may be given before surgery to shrink the tumour and improve the chances of complete removal while preserving normal bowel and sphincter function.
Rectal cancer occurs when abnormal cells in the rectum grow uncontrollably and form a tumour. As the disease progresses, cancer cells may invade surrounding tissues or spread to nearby lymph nodes and distant organs such as the liver or lungs.
Early diagnosis and appropriate staging are important because treatment differs significantly between early-stage and locally advanced or metastatic rectal cancer.
There is usually no single identifiable cause of rectal cancer. It develops through genetic and cellular changes that allow abnormal cells to grow and survive. Factors that may contribute to the development of colorectal cancer include:
Having a risk factor does not necessarily mean that a person will develop rectal cancer.
Some patients may have no symptoms during the early stages. When symptoms occur, they can include:
The risk of developing rectal cancer may increase with:
A doctor may recommend several tests to diagnose and stage rectal cancer:
Rectal cancer is commonly staged using the TNM system, which considers the primary tumour, lymph nodes and distant spread.
Abnormal or cancerous cells are confined to the innermost lining of the rectum.
The cancer has grown into deeper layers of the rectal wall but has not spread to nearby lymph nodes or distant organs.
The cancer has grown through the rectal wall and may extend into nearby tissues, but it has not spread to nearby lymph nodes.
The cancer has spread to nearby lymph nodes but has not spread to distant organs.
The cancer has spread to distant organs or tissues, commonly including the liver or lungs.
Treatment is individualized within each stage because tumour location, molecular features, response to treatment and the patient's overall health can influence the treatment plan.
Treatment may involve one or more of the following:
The goal of surgery is to remove the cancer completely while preserving bowel function and, when safely possible, the anal sphincter.
Rectal cancer can be curable, particularly when diagnosed before it has spread to distant organs. The possibility of cure depends on factors such as stage, tumour biology, response to treatment and whether the cancer can be completely removed.
There is no single treatment that is best for every patient. Depending on the stage and tumour characteristics, treatment may include surgery, chemotherapy, radiation, chemoradiation, total neoadjuvant therapy, targeted therapy or immunotherapy.
No. Some very early cancers may be treated with local excision, while selected patients who have a complete response to neoadjuvant treatment may be considered for active surveillance. However, surgery remains an important treatment for many patients.
Not necessarily. Some operations allow the bowel to be reconnected. A temporary ileostomy may be used to protect a surgical connection. In some cases, particularly when the tumour involves the anal sphincter or is very close to the anus, a permanent colostomy may be required.
In selected cases, particularly when a complete clinical response is achieved after appropriate neoadjuvant treatment, active surveillance may be considered. This is not appropriate for everyone and requires strict monitoring.
It can be given before and/or after surgery depending on the stage and treatment strategy. For locally advanced disease, chemotherapy and radiation may be incorporated into treatment before surgery.
Yes. Radiation therapy has an important role in treating many rectal cancers, particularly locally advanced disease. It is frequently combined with chemotherapy and may be administered before surgery.
Yes. Advanced rectal cancer can spread to distant organs, most commonly the liver and lungs. Treatment for metastatic disease may include systemic therapy, surgery or other local treatments depending on where and how extensively the cancer has spread.
Yes. Recurrence can occur locally or in distant organs. Regular follow-up after treatment is therefore important.
Consult a doctor if you experience persistent rectal bleeding, unexplained changes in bowel habits, blood in the stool, unexplained weight loss, persistent abdominal or rectal discomfort, or other symptoms that concern you. Early evaluation can help identify the cause and, when cancer is present, facilitate timely treatment.
Choosing the right cancer centre is an important decision, particularly for rectal cancer, where treatment may involve surgery, chemotherapy, radiation therapy, and careful long-term follow-up. Sanjivani Cancer Centre focuses on advanced cancer surgery, minimally invasive techniques and personalized cancer care.
At Sanjivani Cancer Centre, the goal is to combine oncological expertise, advanced surgical techniques, personalized treatment planning and compassionate care to help patients receive appropriate treatment for rectal cancer.
Visit our clinics across various locations for expert consultation